These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 16083524)
1. Renal protection by radical scavenging in cardiac surgery patients. Fischer UM; Tossios P; Mehlhorn U Curr Med Res Opin; 2005 Aug; 21(8):1161-4. PubMed ID: 16083524 [TBL] [Abstract][Full Text] [Related]
2. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial. Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724 [TBL] [Abstract][Full Text] [Related]
3. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Haase M; Haase-Fielitz A; Bagshaw SM; Reade MC; Morgera S; Seevenayagam S; Matalanis G; Buxton B; Doolan L; Bellomo R Crit Care Med; 2007 May; 35(5):1324-31. PubMed ID: 17414730 [TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Sisillo E; Ceriani R; Bortone F; Juliano G; Salvi L; Veglia F; Fiorentini C; Marenzi G Crit Care Med; 2008 Jan; 36(1):81-6. PubMed ID: 18090169 [TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine does not prevent hepatorenal ischaemia-reperfusion injury in patients undergoing orthotopic liver transplantation. Hilmi IA; Peng Z; Planinsic RM; Damian D; Dai F; Tyurina YY; Kagan VE; Kellum JA Nephrol Dial Transplant; 2010 Jul; 25(7):2328-33. PubMed ID: 20179007 [TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial. Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432 [TBL] [Abstract][Full Text] [Related]
8. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions. Ramesh N; Pillai RK; Abraham T; Padmaja NP; Hameed S; Vijayaraghavan G J Assoc Physicians India; 2006 Jun; 54():449-52. PubMed ID: 16909692 [TBL] [Abstract][Full Text] [Related]
9. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial. Adabag AS; Ishani A; Koneswaran S; Johnson DJ; Kelly RF; Ward HB; McFalls EO; Bloomfield HE; Chandrashekhar Y Am Heart J; 2008 Jun; 155(6):1143-9. PubMed ID: 18513531 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention. Seyon RA; Jensen LA; Ferguson IA; Williams RG Heart Lung; 2007; 36(3):195-204. PubMed ID: 17509426 [TBL] [Abstract][Full Text] [Related]
11. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography. Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012 [TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery. Barr LF; Kolodner K Crit Care Med; 2008 May; 36(5):1427-35. PubMed ID: 18434903 [TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis. Nigwekar SU; Kandula P Ann Thorac Surg; 2009 Jan; 87(1):139-47. PubMed ID: 19101287 [TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial. Hynninen MS; Niemi TT; Pöyhiä R; Raininko EI; Salmenperä MT; Lepäntalo MJ; Railo MJ; Tallgren MK Anesth Analg; 2006 Jun; 102(6):1638-45. PubMed ID: 16717300 [TBL] [Abstract][Full Text] [Related]
15. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial. Kaya K; Oğuz M; Akar AR; Durdu S; Aslan A; Erturk S; Taşöz R; Ozyurda U Eur J Cardiothorac Surg; 2007 Feb; 31(2):290-7. PubMed ID: 17174559 [TBL] [Abstract][Full Text] [Related]
16. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON). Komisarof JA; Gilkey GM; Peters DM; Koudelka CW; Meyer MM; Smith SM Crit Care Med; 2007 Feb; 35(2):435-41. PubMed ID: 17205018 [TBL] [Abstract][Full Text] [Related]
17. Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair-a randomized controlled trial. Macedo E; Abdulkader R; Castro I; Sobrinho AC; Yu L; Vieira JM Nephrol Dial Transplant; 2006 Jul; 21(7):1863-9. PubMed ID: 16522657 [TBL] [Abstract][Full Text] [Related]
18. Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography. MacNeill BD; Harding SA; Bazari H; Patton KK; Colon-Hernadez P; DeJoseph D; Jang IK Catheter Cardiovasc Interv; 2003 Dec; 60(4):458-61. PubMed ID: 14624421 [TBL] [Abstract][Full Text] [Related]
19. Renal function after cardiopulmonary bypass surgery in patients with impaired renal function. A randomized study of the effect of nifedipine. Witczak BJ; Hartmann A; Geiran OR; Bugge JF Eur J Anaesthesiol; 2008 Apr; 25(4):319-25. PubMed ID: 18182121 [TBL] [Abstract][Full Text] [Related]
20. The effects of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgery. Köksal H; Rahman A; Burma O; Halifeoğlu I; Bayar MK Anadolu Kardiyol Derg; 2008 Dec; 8(6):437-43. PubMed ID: 19103540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]